2008/2009 BIOTECHNOLOGY RESEARCH REVIEW
Foreword
The global economic downturn that began in 2008 has slowed growth in nearly all technology sectors, including biotechnology markets. Nonetheless, the high value that biotechnology products can deliver, and the long-term growth potential of the sector will surely result in increased capital input and long-term sustained growth when the global economy recovers.
BCC Research has provided comprehensive coverage of biotechnology markets for many years, and we are now increasing our production of biotechnology market research reports. This review of biotechnology market research conducted in 2008 and the first half of 2009 is meant to provide a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision-making since BCC was founded in 1971.
This review includes highlights of reports published by BCC Research on the following biotechnology markets:
- Synthetic Biology
- Commercial Amino Acids
- Monoclonal Therapeutics and Companion Diagnostic Products
- Environmental Markets for Biotechnology
- Protein Drugs
- Botanical and Plant-derived Drugs
- Stem Cells
- RNA Interference
- DNA Diagnostics
- Biologic Imaging Reagents
We hope you find this Research Review valuable, and we look forward to serving our customers’ biotechnology market research needs
Kevin R. Fitzgerald
Editorial Director
BCC Research
Report Code: BIO069A, Published: July 2009, Analyst:
